This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Dexamethasone tests

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Dexamethasone is a potent synthetic glucocroticoid which in a normal person produces feedback suppression of CRH and ACTH and consequently, serum cortisol.

Low dose suppression tests are used in screening and as a confirmatory test of Cushing's syndrome:

  • oral dexamethasone 0.5 mg qds for 48 hr - start 0900
  • measure serum cortisol at 0900 hrs, basally and at 48 hr
  • serum cortisol level should fall to less than 50 nmol per litre by radioimmunoassay in normal patients. Non-suppression suggests Cushings syndrome

High dose tests help to differentiate the cause:

  • oral dexamethasone 2.0 mg qds for 48 hr - start 0900
  • measure serum cortisol at 0900 hrs, basally and at 48 hr
  • fall in cortisol to less than 50% of the basal value at 48 hrs suggests pituitary Cushing's disease. Ectopic ACTH secretion and adrenal tumours are not suppressed

Some patients with psychiatric disorders such as depression, mania and chronic schizophrenia fail to show cortisol suppression following dexamethasone administration.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.